Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2017 | ImMAGE Biotherapeutics Announces Termination of Operations | CI |
2017 | ImMAGE Biotherapeutics Initiates Repeat Toxicology Study for Lead Candidate, IMT-001 | CI |
Sales 2015 | - | Sales 2016 | - | Capitalization | 4.61Cr 384.33Cr |
---|---|---|---|---|---|
Net income 2015 | - 0 | Net income 2016 | - 0 | EV / Sales 2015 * | - |
Net Debt 2015 | 15.23T 12.7L | Net cash position 2016 | 1L 1.2Cr | EV / Sales 2016 | - |
P/E ratio 2015 * |
-
| P/E ratio 2016 |
-211
x | Employees | 4 |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 30.14% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Narayanan
FOU | Founder | 35 | 21/12/21 |
Anton Dormer
FOU | Founder | 60 | 21/12/21 |
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Cong Mou
CEO | Chief Executive Officer | 41 | - |
Elton Norman
DFI | Director of Finance/CFO | 61 | - |
Anton Dormer
FOU | Founder | 60 | 21/12/21 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 151 | |
+6.11% | 11TCr | |
-4.67% | 6.38TCr | |
+73.81% | 4.53TCr | |
+15.46% | 3.89TCr | |
+5.46% | 3.31TCr | |
+11.59% | 2.02TCr | |
+13.74% | 1.69TCr | |
+20.05% | 1.61TCr | |
+5.02% | 1.45TCr |
- Stock Market
- Equities
- IMMG Stock